Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Ochi

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
JACC. Asia|July 23, 2025
Systolic Dyssynchrony Index: A Possible Robust Parameter for Risk Stratification of SCD in HCM?Yuri Ochi, Toru Kubo, Hiroaki Kitaoka
Heart (British Cardiac Society)|April 9, 2014
Repeated heart failure in a 74-year-old man with left ventricular hypertrophyYuri Ochi, Toru Kubo, Hiroaki Kitaoka
Internal Medicine (Tokyo, Japan)|June 11, 2025
Unveiling the Sword: Noninvasive Scimitar Vein AssessmentNatsuko Ishii, Yuichi Baba, Yuri Ochi, et al.
Internal Medicine (Tokyo, Japan)|February 1, 2026
Effect of Transthyretin Stabilizer in Transthyretin Cardiac AmyloidosisToru Kubo, Yuri Ochi, Yuichi Baba, et al.
CASE (Philadelphia, Pa.)|March 3, 2025
Dove-Coo Murmur From Pulmonary Regurgitation Is Associated With Tiger Stripes SignYuri Ochi, Toru Kubo, Naohito Yamasaki, et al.
Circulation Reports|December 24, 2021
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis　- ReplyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Circulation Reports|December 11, 2025
Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy PatientsYuichi Baba, Yuri Ochi, Toru Kubo, et al.
CASE (Philadelphia, Pa.)|October 6, 2025
Is This a "True" Apical Sparing Pattern?Yui Yamamoto, Yuri Ochi, Toru Kubo, et al.
CASE (Philadelphia, Pa.)|July 1, 2021
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic CardiomyopathyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Molecular Genetics and Metabolism Reports|October 26, 2020
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type IKenta Sugiura, Toru Kubo, Yuri Ochi, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
JACC. Asia|July 23, 2025
Systolic Dyssynchrony Index: A Possible Robust Parameter for Risk Stratification of SCD in HCM?Yuri Ochi, Toru Kubo, Hiroaki Kitaoka
Heart (British Cardiac Society)|April 9, 2014
Repeated heart failure in a 74-year-old man with left ventricular hypertrophyYuri Ochi, Toru Kubo, Hiroaki Kitaoka
Internal Medicine (Tokyo, Japan)|June 11, 2025
Unveiling the Sword: Noninvasive Scimitar Vein AssessmentNatsuko Ishii, Yuichi Baba, Yuri Ochi, et al.
Internal Medicine (Tokyo, Japan)|February 1, 2026
Effect of Transthyretin Stabilizer in Transthyretin Cardiac AmyloidosisToru Kubo, Yuri Ochi, Yuichi Baba, et al.
CASE (Philadelphia, Pa.)|March 3, 2025
Dove-Coo Murmur From Pulmonary Regurgitation Is Associated With Tiger Stripes SignYuri Ochi, Toru Kubo, Naohito Yamasaki, et al.
Circulation Reports|December 24, 2021
Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis　- ReplyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Circulation Reports|December 11, 2025
Discontinuation of Tafamidis in Wild-Type Transthyretin Amyloid Cardiomyopathy PatientsYuichi Baba, Yuri Ochi, Toru Kubo, et al.
CASE (Philadelphia, Pa.)|October 6, 2025
Is This a "True" Apical Sparing Pattern?Yui Yamamoto, Yuri Ochi, Toru Kubo, et al.
CASE (Philadelphia, Pa.)|July 1, 2021
A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic CardiomyopathyYuri Ochi, Toru Kubo, Yuichi Baba, et al.
Molecular Genetics and Metabolism Reports|October 26, 2020
Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type IKenta Sugiura, Toru Kubo, Yuri Ochi, et al.
Pageof 6